Mr. Hanson joined the board Oct. 27, according to a news release. He will serve on Walgreens’ compensation and leadership performance committee and its finance and technology committee.
Before joining Zimmer Biomet five years ago, Mr. Hanson was executive vice president and president of the minimally invasive therapies group at Medtronic, where he “provided strategic direction to Medtronic’s approximately $9 billion minimally invasive therapies business” after the devicemaker acquired Covidien in 2015, where he started his career and worked for 22 years.
“Bryan is a tremendous addition to our board of directors,” Roz Brewer, Walgreens Boots Alliance CEO, said in a statement.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
